Health
Novo Nordisk Halts Two Trials of Inflammation-Reducing Drug for Heart Health
By Editor • September 7, 2026 • 1 min read
Novo Nordisk has halted two trials of ziltivekimab, a drug aimed at reducing inflammation for heart health, due to low chances of success.
Read more